REDHILL BIOPHARMA LTD. Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement
REDHILL BIOPHARMA LTD. (RDHL) had Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement of 37.77 thousand shares as of 2024-12-31, per its 20-F filed 2025-04-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement · last filed 2025-04-10
- 2023-12-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 178.02K EquityInstruments.
- 2022-12-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 91.14K EquityInstruments; Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement as first filed 3.65M EquityInstruments.
EquityInstruments
| Period end | Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement | Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement as first filed |
|---|---|---|
| 2023-12-31 | 178.02K EquityInstruments 20-F · filed 2024-04-08 | |
| 2022-12-31 | 91.14K EquityInstruments 20-F · filed 2024-04-08 | 3.65M EquityInstruments 20-F · filed 2023-04-28 |
shares
| Period end | Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement |
|---|---|
| 2024-12-31 | 37.77K shares 20-F · filed 2025-04-10 |
| 2023-12-31 | 7.12K shares 20-F · filed 2025-04-10 |
| 2022-12-31 | 3.65K shares 20-F · filed 2025-04-10 |